PROTO SCRIPT PHARMACEUTICAL CORP Deferred Tax Assets, Valuation Allowance

PROTO SCRIPT PHARMACEUTICAL CORP Deferred Tax Assets, Valuation Allowance

PROTO SCRIPT PHARMACEUTICAL CORP had Deferred Tax Assets, Valuation Allowance of $147.97 thousand as of 2016-12-31, per its 10-K/A filed 2017-10-19.

Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2017-10-19

• 2016-12-31: Deferred Tax Assets, Valuation Allowance $147.97K.
• 2014-05-31: Deferred Tax Assets, Valuation Allowance $36.73K.
• 2013-05-31: Deferred Tax Assets, Valuation Allowance $23.73K.
• 2012-05-31: Deferred Tax Assets, Valuation Allowance $12.70K.